What is Profluent Bio?
Founded in 2022 and headquartered in Berkeley, CA, Profluent Bio is at the forefront of revolutionizing biomedicine through advanced AI. The company specializes in developing deep generative models to design and validate novel, functional proteins. This cutting-edge technology positions Profluent Bio as a key player in the synthetic biology and AI-driven drug discovery sectors, aiming to accelerate the development of new therapeutics and biotechnological solutions.
How much funding has Profluent Bio raised?
Profluent Bio has raised a total of $141M across 2 funding rounds:
Other Financing Round
$35M
Other Financing Round
$106M
Other Financing Round (2024): $35M with participation from Insight Partners, Air Street Capital, and Spark Capital
Other Financing Round (2025): $106M led by Insight Partners, Bezos Expeditions, Altimeter Capital, and Spark Capital
Key Investors in Profluent Bio
Insight Partners
Insight Partners is a global venture capital and private equity firm that invests in high-growth software and technology companies. It provides capital and hands-on operational support to help businesses scale from early stage to IPO, focusing on enterprise software, SaaS, and internet platforms.
Bezos Expeditions
Bezos Expeditions is an investment firm founded by Jeff Bezos that focuses on a diverse range of sectors including technology, healthcare, and space exploration. The firm is known for its strategic investments in innovative companies such as Airbnb, Uber, and Twitter.
Altimeter Capital
Altimeter Capital is an investment firm that partners with technology companies from early growth through public markets. It manages concentrated, long term portfolios and works closely with founders and teams to support product, strategy and durable value creation.
What's next for Profluent Bio?
With this major strategic investment, Profluent Bio is poised for accelerated scaling and further development of its AI-driven protein design platform. The substantial capital infusion is expected to fuel research and development initiatives, expand its team of AI and biotech experts, and enhance its capabilities in designing and validating functional proteins. This funding round signals a strong trajectory for the company as it aims to make significant advancements in revolutionizing biomedicine.
See full Profluent Bio company page
